Study of Cilofexor in Adults With Primary Sclerosing Cholangitis

Stopped Following recommendation of the external Data Monitoring Committee, after it reviewed the results of a planned interim futility analysis.

Conditions

• Primary Sclerosing Cholangitis

Interventions

• DRUG: Cilofexor
• DRUG: Placebo

Sponsor

Gilead Sciences